- Home
- IRON
IRON
Disc Medicine Inc.
as 12-17-2024 4:00pm EST
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 1.4B | IPO Year: | N/A |
| Target Price: | $73.70 | AVG Volume (30 days): | 253.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.60 - $77.60 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Disc Medicine Inc. (IRON)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| White William Richard | IRON | Director | Dec 2 '24 | Sell | $64.47 | 1,957 | $126,489.66 | 1,935 | |
| Savage William Jacob | IRON | Chief Medical Officer | Nov 25 '24 | Sell | $65.93 | 14,183 | $928,326.48 | 45,851 | |
| Savage William Jacob | IRON | Chief Medical Officer | Nov 15 '24 | Sell | $60.27 | 9,158 | $546,152.60 | 45,851 | |
| White William Richard | IRON | Director | Nov 1 '24 | Sell | $52.24 | 7,337 | $427,525.88 | 1,935 | |
| White William Richard | IRON | Director | Oct 1 '24 | Sell | $50.88 | 201 | $10,312.44 | 1,935 |
Latest Disc Medicine Inc. News
IRON Breaking Stock News: Dive into IRON Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Disc Medicine Presents Data Showing Potential Benefits of 3 Investigational Drugs
GlobeNewswire
9 days ago
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire
9 days ago
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
TipRanks
24 days ago
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
GlobeNewswire
a month ago
Disc Medicine to Participate in Upcoming Investor Conferences
MT Newswires
a month ago
Wedbush Raises Disc Medicine Price Target to $83 From $75, Maintains Outperform Rating
MT Newswires
a month ago
Disc Medicine's Q3 Net Loss Widens
GlobeNewswire
a month ago
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update
Compare IRON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRON Disc Medicine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.